Revalesio is a pioneering biotechnology company dedicated to restoring hope and transforming lives. Founded in 2000 and based in Tacoma, Washington, Revalesio has partnered with leaders in biomedical research from around the world and has more than 140 patents in various stages of prosecution. The company is pioneering a novel class of anti-inflammatory products and is targeting neuro-inflammatory, respiratory, cardiovascular and other inflammatory mediated diseases.